5.41
0.02 (0.28%)
| Penutupan Terdahulu | 5.40 |
| Buka | 5.36 |
| Jumlah Dagangan | 905,392 |
| Purata Dagangan (3B) | 1,115,087 |
| Modal Pasaran | 703,209,408 |
| Harga / Jualan (P/S) | 3.53 |
| Harga / Buku (P/B) | 2.29 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2026 |
| Margin Keuntungan | -5.71% |
| Margin Operasi (TTM) | -36.12% |
| EPS Cair (TTM) | -0.090 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -7.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 75.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.19% |
| Nisbah Semasa (MRQ) | 5.62 |
| Aliran Tunai Operasi (OCF TTM) | 21.30 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 30.18 M |
| Pulangan Atas Aset (ROA TTM) | -3.51% |
| Pulangan Atas Ekuiti (ROE TTM) | -2.91% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Cytek Biosciences, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.5 |
| Penilaian Relatif | 5.0 |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | 0.86 |
|
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 9.15% |
| % Dimiliki oleh Institusi | 62.13% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |